CYTOKINETICS INC CYTK

Latest FY: 2025 Healthcare Biotechnology
Market Price $73.94
Market Cap $10.04B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑376.6% YoY
$88.04M
3-Yr CAGR: -2.4%
Net Income ↓-33.2% YoY
-$784.96M
Net Margin: -891.6%
Free Cash Flow ↓-33.8% YoY
-$534.82M
FCF Yield: -5.33%
EPS (Diluted) ↓-24.3% YoY
$-6.54
Basic: $-6.54
Return on Equity Efficiency
N/A
ROA: -55.1%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (CYTK)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2024: Revenue YoY (+145.3%) is identical to Gross Profit YoY (+145.3%). Verify the underlying Revenue and Gross Profit values for FY 2024 and FY 2023.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $106.4M $103.7M $16.5M $0.39 0.00% $37.0M $35.4M
FY 2017 $13.4M -87.4% $10.4M $-127.8M -876.7% $-2.59 -764.1% 0.00% $-101.8M $-104.6M -395.7%
FY 2018 $31.5M +135.6% $27.7M $-106.3M +16.8% 0.00% $-101.2M $-102.1M +2.4%
FY 2019 $26.9M -14.7% $20.2M $-121.7M -14.5% 0.00% $-90.9M $-93.5M +8.4%
FY 2020 $55.8M +107.8% $39.9M $-127.3M -4.6% 0.00% $8.9M $-2.1M +97.7%
FY 2021 $70.4M +26.2% $54.0M $-215.3M -69.2% 0.00% $-142.5M $-191.4M -8,975.1%
FY 2022 $94.6M +34.3% $75.2M $-389.0M -80.6% $-4.33 0.00% $-299.5M $-310.9M -62.4%
FY 2023 $7.5M -92.0% $7.5M $-526.2M -35.3% $-5.45 -25.9% 0.00% $-414.3M $-415.7M -33.7%
FY 2024 $18.5M +145.3% $18.5M $-589.5M -12.0% $-5.26 +3.5% 0.00% $-395.9M $-399.8M +3.8%
FY 2025 $88.0M +376.6% $42.5M $-785.0M -33.2% $-6.54 -24.3% 0.00% $-510.0M $-534.8M -33.8%
$

Valuation

Market Price $73.94
Market Cap $10.04B
Enterprise Value $10.20B
P/E Ratio N/A
P/B Ratio N/A
FCF Yield -5.33%
Dividend Yield N/A
Shares Outstanding 135,770,600
%

Profitability & Margins

Gross Margin 48.23%
Operating Margin -695.44%
Net Margin -891.60%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) -55.10%
Asset Turnover 0.06x
Revenue 3-Yr CAGR -2.36%
🛡️

Financial Health & Liquidity

Current Ratio 4.53
Cash Ratio 0.61
Debt / Equity -0.436
Debt / Assets 0.202
Cash & Equivalents $122.52M
Total Debt $287.56M
Book Value / Share $-4.86
💧

Cash Flow Efficiency

Operating Cash Flow -$510.01M
Capital Expenditures (CapEx) $24.81M
Free Cash Flow -$534.82M
OCF / Revenue -579.30%
FCF / Revenue -607.48%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-6.54
EPS (Basic) $-6.54
Dividends / Share N/A
Book Value / Share $-4.86
EPS YoY Growth -24.33%
🏛️

Balance Sheet (FY 2025)

Total Assets $1.42B
Total Liabilities $2.08B
Stockholders' Equity -$659.62M
Current Assets $916.98M
Current Liabilities $202.45M